Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Marksans Pharma Ltd.	Income Statement

NSE: MARKSANSEQ BSE: 524404ISIN: INE750C01026INDUSTRY: Pharmaceuticals

BSE

Rs 254.45

Open: 220.70

Today's Range 218.10

258.85

NSE
Rs 254.79
+34.53 (+ 13.55 %)

+34.20 (+ 13.44 %)

Prev Close: 220.25

52 Week Range 156.00

270.60

You can view the Income Statement for the last 5 years.

Market Cap. (Rs.)	11546.16 Cr.	P/BV	4.12	Book Value (Rs.)	61.83
52 Week High/Low (Rs.)	271/155	FV/ML	1/1	P/E(X)	30.34
Bookclosure	01/08/2025	EPS (Rs.)	8.40	Div Yield (%)	0.31

(Rs. in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00


INCOME
Revenue From Operations [Net]	2950.94	2614.45	2174.20	1849.62	1480.12
Other Operating Revenues	0.00	8.40	3.21	2.52	10.72
Total Operating Revenues	2950.94	2622.85	2177.41	1852.14	1490.84

Other Income	82.53	70.38	50.42	59.31	41.85
Total Revenue	3033.47	2693.22	2227.83	1911.45	1532.69

EXPENSES
Cost Of Materials Consumed	959.21	753.02	667.70	612.97	540.67
Purchase Of Stock-In Trade	454.49	574.48	444.28	314.78	163.25
Changes In Inventories Of FG,WIP And Stock-In Trade	-136.42	-183.76	-73.86	-6.39	12.90
Employee Benefit Expenses	420.93	350.30	293.64	239.37	220.30
Finance Costs	24.13	11.66	11.20	9.13	8.45
Depreciation And Amortisation Expenses	98.63	83.39	74.27	51.85	44.78
Other Expenses	651.95	600.17	387.07	352.09	294.84
Total Expenses	2472.92	2189.25	1804.30	1573.80	1285.18

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	560.56	503.97	423.53	337.65	247.51

Profit/Loss Before Tax	560.56	503.97	423.53	337.65	247.51

Tax Expenses-Continued Operations
Current Tax	140.49	127.28	113.31	71.57	57.10
Deferred Tax	0.00	-7.24	-5.11	1.10	3.59
Tax For Earlier Years	0.00	1.31	0.43	-0.33	0.01
Total Tax Expenses	140.49	121.35	108.63	72.33	60.70
Profit/Loss After Tax And Before ExtraOrdinary Items	420.06	382.62	314.90	265.32	186.81

Profit/Loss From Continuing Operations	420.06	382.62	314.90	265.32	186.81

Profit/Loss For The Period	420.06	382.62	314.90	265.32	186.81

Minority Interest	-2.16	-2.04	-1.20	0.99	0.00
Consolidated Profit/Loss After MI And Associates	417.90	380.58	313.70	266.31	186.81

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	9.22	8.40	6.92	6.41	4.51
Diluted EPS (Rs.)	9.22	8.40	6.92	6.41	4.51

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	27.19	22.66	10.17	10.23

Market

Derivatives

Mutual Fund

IPO

Quick Links

Marksans Pharma Ltd.

Income Statement